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Abstract Vertebroplasty and kyphoplasty have become
common surgical techniques for the treatment of vertebral
compression fractures. Vertebroplasty involves the per-
cutaneous injection of bone cement into the cancellous
bone of a vertebral body with the goals of pain alleviation
and preventing further loss of vertebral body height.
Kyphoplasty utilizes an inﬂatable balloon to create a
cavity for the cement with the additional potential goals
of restoring height and reducing kyphosis. Vertebroplasty
and kyphoplasty are effective treatment options for the
reduction of pain associated with vertebral body com-
pression fractures. Biomechanical studies demonstrate that
kyphoplasty is initially superior for increasing vertebral
body height and reducing kyphosis, but these gains are
lost with repetitive loading. Complications secondary to
extravasation of cement include compression of neural
elements and venous embolism. These complications are
rare but more common with vertebroplasty. Vertebropl-
asty and kyphoplasty are both safe and effective
procedures for the treatment of vertebral body compres-
sion fractures.
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Introduction
In the past two decades, vertebroplasty and kyphoplasty
have emerged as surgical options that play a central role
in the treatment of vertebral compression fractures. Before
the common use of vertebroplasty and kyphoplasty, the
principal surgical option for treatment of compression
fractures was decompression and fusion. However, surgi-
cal ﬁxation frequently failed in elderly patients because of
osteopenia [1]. Vertebroplasty was ﬁrst introduced in 1987
by Galibert et al. [2], who successfully treated seven
patients who had painful vertebral angiomas. Since then,
the use of vertebroplasty has expanded to include treat-
ment of osteoporotic compression fractures [3, 4],
traumatic compression fractures [5, 6], and metastatic
compression fractures [7, 8]. Osteoporotic compression
fractures are now the most common indication for this
procedure.
Vertebroplasty involves the percutaneous injection of
cement, such as polymethylmethacrylate (PMMA),
directly into the cancellous bone of a vertebral body with
the goal of alleviating pain associated with a vertebral
compression fracture and preventing further loss of ver-
tebral body height or progression of kyphotic deformity.
Kyphoplasty was introduced later as a modiﬁcation of
vertebroplasty in which a balloon tamp is inﬂated in the
vertebral body to compress the cancellous bone and
create a cavity. Theoretically, the cavity allows the
cement to be injected under less pressure and minimizes
extravasation. Additional goals of kyphoplasty include
restoring vertebral body height and reducing kyphosis [9].
Since the inception of these procedures, a vast body of
literature has been generated in an attempt to evaluate
and compare them. Although there have been no pub-
lished results of randomized controlled trials comparing
vertebroplasty and kyphoplasty, recent systematic reviews
help illustrate the similarities and differences of the two
procedures with regards to treatment efﬁcacy and com-
plication risks.
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A 15% loss of vertebral body height constitutes a vertebral
compression fracture. The leading cause of vertebral
compression fractures is osteoporosis, with an estimated
annual incidence of 700,000 osteoporotic vertebral body
compression fractures [10]. Twenty-six percent of women
older than 50 years have a vertebral compression fracture
[11], and the prevalence increases to 40% by the age of
80 years [12].
Osteoporotic vertebral compression fractures have
become a major national health issue because of their high
incidence, increasing associated costs [13], and deleterious
sequelae. An estimated 84% of vertebral compression
fractures are associated with pain [10]. Acute pain typically
lasts approximately 4–6 weeks, with the pain occurring
axially and correlating with the level of fracture. Activity
aggravates the pain whereas lying down or sitting alleviates
the pain. Point tenderness is a common ﬁnding on exami-
nation but is not present in 10% of cases and therefore
should not be considered a requisite ﬁnding for surgical
intervention [14]. Chronic pain occurs in one-third of
vertebral compression fractures and is more likely to ensue
when one level is severely collapsed or multiple levels are
involved [15, 16]. Loss of vertebral body height, thoracic
kyphosis, and pain can also contribute to impaired pul-
monary function, with the severity of pulmonary function
decline correlating with the severity of spinal column
deformity [17, 18]. Other side effects of vertebral com-
pression fracture include impaired mobility, limited
exercise tolerance, chronic depression, and an increased
likelihood of death [19].
Medical therapies for vertebral compression fractures
include analgesics, bed rest, bracing, and rehabilitation [20,
21]. In patients with osteoporosis, weight-bearing exercise
is crucial in the prevention of disease progression [22], and
therefore bed rest can be counterproductive in the long
run. Medical treatment of osteoporosis includes calcium
supplements, vitamin D, hormone replacement, and bis-
phosphonates [23]. Of note, none of these conservative
therapies help restore loss of height or reduce kyphotic
deformity [21].
Patient selection for vertebroplasty and kyphoplasty
Patients likely to beneﬁt from vertebroplasty or kyphopl-
asty have a history of pain that correlates well with the
level of a recent compression fracture. If a patient has
multiple adjacent compression fractures, radiographic
studies are helpful for identifying which level(s) should be
treated. A T2-weighted magnetic resonance imaging or
STIR sequence with magnetic resonance imaging will
demonstrate increased signal intensity associated with
edema in recent fractures [24]. A bone scan can also reveal
more recent fractures, and increased activity is highly
prognostic of a clinical response to vertebroplasty with a
positive predictive value of 93% [25]. The use of computed
tomography may also be helpful to determine the integrity
of the posterior cortical wall and pedicle sizes. If the
pedicles are small, the surgeon may more heavily consider
a vertebroplasty with a smaller needle to avoid using the
larger trocar and facing an increased risk of pedicle vio-
lation with kyphoplasty [15]. Potential contraindications to
surgery include uncorrected coagulopathy, active infection,
spinal canal compromise, radiculopathy, posterior vertebral
body cortical fractures, and severe ([75%) vertebral body
collapse [26–30].
Technical aspects
The principal concerns when performing a vertebroplasty
or kyphoplasty are proper placement of the needle or trocar
for injection of the cement and avoiding extravasation of
the cement, which can lead to compression of neural ele-
ments or venous embolism. Fluoroscopy is required for
insertion of the trocar, with a goal of the trocar being
placed in the anteromedial portion of the vertebral body.
The results of both clinical [31] and ex vivo biomechanical
studies [32, 33] suggest that a unipedicular approach can be
as effective as a bipedicular approach. A transpedicular
approach is reasonable if the pedicles are at least 4–5 mm
wide. If the pedicles are too small to cannulate, as fre-
quently occurs above T8, a lateral extrapedicular trajectory
can be used. After the location of the trocar is conﬁrmed,
some authors prefer to use antecedent venography with
contrast before the injection of cement to avoid a venous
embolism [34], while others have concluded that this
maneuver does not help avoid complications [14, 35]. If
there is concern about venous or transcortical extravasa-
tion, the trocar may be moved or the cement may be
allowed to solidify more before it is injected. The cement
should be injected under live ﬂuoroscopy and halted once
the cement enters the posterior third of the vertebral body.
Several options are now available for use as a cement or
ﬁlling material. Desirable characteristics for a ﬁlling
material include good biocompatibility, adequate biome-
chanical strength and stiffness, and radiopacity. PMMA has
been used for several decades in orthopedic procedures and
it is the most commonly employed substance for ﬁlling
material. Several PMMA cements have been marketed,
including Cranioplastic (CMW, Blackpool, England),
Osteobond (Zimmer, Warsaw, IN), Simplex P (Stryker-
Howmedica-Osteonics, Rutherford, NJ), and Fixos (Tran-
systeme, Nimes, France). Biomechanical studies have
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not restore vertebral body stiffness, but strength is
increased compared with prefracture values. Although
differences in biomechanical properties such as compres-
sive strength and modulus do exist between different
PMMA preparations, these differences do not appear to be
clinically relevant [38–40]. Alternatives to PMMA with
similar biomechanical properties for strength and stiffness
include calcium sulfate cement [41] and calcium phos-
phate cement [42–44]. BoneSource (Tryker-Howmedica-
Osteonics, Rutherford, NJ), a hydroxyapatite cement,
results in signiﬁcantly less vertebral body strength than
PMMA cements in ex vivo biomechanical studies of both
vertebroplasty [37] and kyphoplasty [36]. Orthocomp
(Orthovita, Malvern, PA), a bioactive glass cement that is
naturally radiopaque, has better compressive strength and
modulus than PMMA cements, suggesting that less
Orthocomp would be required for mechanical stabilization
of a fracture than a PMMA cement [38, 45].
Biomechanics
Vertebroplasty and kyphoplasty have been directly com-
pared in an ex vivo model of osteoporotic cadaveric
fractured vertebral bodies under repetitive loading condi-
tions [46]. Initially after the procedures, patients in the
kyphoplasty group had a signiﬁcantly better mean height
restoration of 2.7 mm, compared with 0.7 mm with ver-
tebroplasty. The height restoration with kyphoplasty
represented a return to 97% of the original height. A
separate ex vivo biomechanical study of kyphoplasty [36]
also found a 97% reversal with kyphoplasty, compared
with 30% with vertebroplasty. However, the initial gains
measured in the study by Kim et al. [46] were lost after
cyclic loading, with patients in the kyphoplasty group
losing an average of 4.2 mm compared with 1.1 mm with
vertebroplasty. The authors hypothesized that the repetitive
loading crushes the weak cancellous bone between the
endplates and cement bolus formed with kyphoplasty. In
contrast, in vertebroplasty, the cement is injected under
more pressure, allowing it to interdigitate in the cancellous
bone and form a continuous cement column between
endplates and thus better resist further compression. This
hypothesis is consistent with the observation that vertebral
bodies had a higher compression stiffness after verteb-
roplasty as compared to kyphoplasty [46]. Although these
ex vivo studies do not exactly replicate a clinical situation,
they clearly illustrate the need for long-term monitoring of
patients to determine whether gains in vertebral height and
kyphotic deformity achieved with vertebroplasty or kyp-
hoplasty are durable.
Clinical efﬁcacy
Criteria that have been used for determining the efﬁcacy of
vertebroplasty and kyphoplasty include reduction of pain,
increase of patient function, and the restoration of vertebral
height or spinal column alignment (Fig. 1). No randomized
controlled trials have been performed to compare verteb-
roplasty directly with kyphoplasty. Numerous retrospective
Fig. 1 Preoperative (a) and
postoperative (b)
roentgenograms of a 63-year-
old patient who underwent
kyphoplasty of a T12
compression fracture. The
anterior vertebral height
increased 4 mm and the
kyphotic deformity decreased
5.6
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parative studies, have been undertaken. Systematic reviews
of the literature have also recently been published that
provide pooled data for an indirect comparison between
vertebroplasty and kyphoplasty.
Taylor et al. [47] published a comparative systematic
review of vertebroplasty and kyphoplasty in cases of ver-
tebral body fractures due to osteoporosis or neoplasm that
included one prospective study comparing vertebroplasty to
medical care, one prospective and two retrospective studies
comparing balloon kyphoplasty to medical care, one pro-
spective study comparing the two procedures, and 70 case
series. In the pooled case series data comprising 4,861
fractures treated by vertebroplasty and 1,070 fractures
treated by kyphoplasty, a similar signiﬁcant reduction of
pain was achieved for vertebroplasty, with up to 5 years of
follow-up, and kyphoplasty, with up to 2 years of follow-
up. Kyphoplasty signiﬁcantly improved functional capacity
measured by the Oswestry Disability Score and Index of
Back Function; reported outcomes with a validated instru-
ment of patient function are lacking for vertebroplasty.
Furthermore, kyphoplasty improved quality of life in six of
eight Short-Form 36 domains reported by patients. Ver-
tebroplasty also improved quality of life in three of four
studies, but results could not be pooled because different
outcome measures were used. Compared with medical
therapy, kyphoplasty was superior for improving both pain
and patient function, whereas vertebroplasty improved
patient function but not pain. In the one study that directly
compared vertebroplasty with kyphoplasty, the authors
found a similar level of pain relief between the two proce-
dures as measured by a Visual Analog Scale, but there was a
notable selection bias in application of the procedures, with
more severe compression fractures receiving kyphoplasty
[48]. In comparative studies [48, 49] and case series, kyp-
hoplasty resulted in signiﬁcant improvement of vertebral
body height and kyphotic deformity. Pooled case series data
also demonstrated improved vertebral height and kyphotic
angle with vertebroplasty.
A second systematic review of vertebroplasty and kyp-
hoplasty encompassing 69 clinical studies was performed
by Hulme et al. [50]; it included 4,456 vertebroplasty
procedures and 1,624 kyphoplasty procedures. For a study
to be included in the analysis, at least 80% of the treated
vertebral compression fractures had to be related to oste-
oporosis. A comparable percentage of patients noted at
least ‘‘some pain relief’’ with vertebroplasty (87%) and
kyphoplasty (92%). Follow-up observation was short
(\1 year) in most studies included in the analysis, but pain
relief was persistent in one retrospective study with 15–
18 months of follow-up [4]. What patient or surgical
factors correlate with successful pain relief have yet to be
elucidated. Physical function and disability scores
improved after both procedures, although results could not
be pooled because of the wide variety of scales employed.
Qualitatively, vertebroplasty and kyphoplasty achieved a
similar improvement in vertebral height if at presentation a
mobile fracture or intravertebral cleft was present. In
pooled data, the mean kyphotic angle restoration was 6.6
for both procedures; however, 34% of kyphoplasty patients
and 39% of vertebroplasty patients did not attain an
improvement in vertebral height or kyphotic deformity.
Some authors have suggested that restoration of vertebral
height is dependent on the age of the fracture [9, 51],
although this ﬁnding is not universal [16].
In summary, direct comparisons between vertebroplasty
and kyphoplasty are not possible because of a lack of pro-
spective data comparing the two approaches. Indirect com-
parisons suggest that vertebroplasty and kyphoplasty reduce
pain comparably. Both procedures appear to improve patient
function in mostseries, althoughavailable data usually cannot
be pooled because of a wide variety of measurement scales.
Vertebral height restoration and reduction of kyphotic defor-
mity are also similar for both procedures.
Vertebroplasty and kyphoplasty may also be used for
fractures due to neoplasm. In the limited number of case
series that have exclusively addressed the application of
vertebroplasty or kyphoplasty to vertebral body fractures
resulting from cancer, the results have been similar to those
for osteoporotic fractures. In a retrospective review of 56
patients with multiple myeloma or metastatic disease who
underwent 65 vertebroplasty and 32 kyphoplasty proce-
dures, 84% of patients had marked or complete pain relief
with a short mean follow-up of 4.5 months [48]. A pro-
spective series of 18 multiple myeloma patients who
underwent 55 kyphoplasty procedures demonstrated
improvement in Short Form-36 scores and a 34% mean
restoration of vertebral height.
Adverse events
The aggregate complication rates of vertebroplasty and
kyphoplasty are small, ranging from \2% when treating
osteoporotic compression fractures to 10% of cases related
to malignant tumors [30, 39, 52, 53]. More serious com-
plications of vertebroplasty and kyphoplasty result from
extravasation of the cement into the epidural space. Com-
pression of neural elements can lead to paralysis with
involvement of the spinal cord [54] or radiculopathy with
compromise of a neural foraman [55]. In one review,
neurological complications were seen in 0.6% of verteb-
roplasty and 0.03% of kyphoplasty cases [50]. Cement may
also ﬂow into venous channels and ultimately lead to a
pulmonary embolism [56–58], which is reported to occur in
0.6 and 0.01% of vertebroplasty and kyphoplasty cases,
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bleeding, and rib fracture or pneumothorax in thoracic
cases. Pedicle fractures may be a more frequent compli-
cation of kyphoplasty because of the larger trocar size [59].
Osteomyelitis is a rare complication that may require
corpectomy [60].
The results of several studies have demonstrated a
higher rate of extravasation with vertebroplasty than with
kyphoplasty. An in vivo study demonstrated signiﬁcantly
less vascular and transcortical extravasation of injected
contrast with kyphoplasty than with vertebroplasty [61]. In
the systematic review by Taylor et al. [47], cement leakage
was signiﬁcantly higher with vertebroplasty (40%) than
with kyphoplasty (8%), and 3% of vertebroplasty leaks
were symptomatic whereas no kyphoplasty leaks were
reported to be symptomatic. Hulme et al. [50] found sim-
ilar rates of extravasation for vertebroplasty (41%) and
kyphoplasty (9%), with subsequent clinical complications
occurring in 3.9 and 2.2% of vertebroplasty and kyphopl-
asty cases, respectively.
The literature is inconclusive on the risk of increased
adjacent level fracture after these procedures, with rates of
adjacent level fractures varying widely for both verteb-
roplasty (8–52%) and kyphoplasty (3–29%) [62–67]. In
contradistinction, kyphoplasty resulted in a decreased
incidence of subsequent vertebral body fractures compared
with medical therapy alone [47]. It is interesting that the
occurrence of new fractures after the procedure is weighted
toward the ﬁrst 30 postoperative days [63, 67], making
extrapolation of normalized annual fracture rates from data
generated by short follow-up periods problematic. In gen-
eral, the literature suggests that the new fracture rate is
higher in patients after one of these procedures than in
subjects with osteoporosis but no fractures [68, 69]. This
comparison may not be justiﬁed, however, because the
presence of one osteoporotic fracture can increase the risk
of developing another fracture up to 12.6-fold [70] and
therefore the observed fracture rate may reﬂect the natural
history of the disease. The higher incidence of fractures in
the early postoperative period could potentially be
explained by increased patient activity and higher stress
secondary to a diminished level of pain. Overall, the cur-
rent data are inconsistent, and no ﬁrm conclusions can be
reached concerning the risk of adjacent level fractures after
vertebroplasty or kyphoplasty.
Future directions
Most clinical experience with vertebroplasty and kyp-
hoplasty has been with compression fractures secondary to
osteoporosis or neoplasm causing back pain, but the
potential indications continue to be expanded. The use of
these procedures in cases involving radicular leg pain
instead of back pain due to vertebral compression fractures,
severe vertebral body collapse, epidural disease impinging
on the spinal canal, burst fractures, and cervical spine
disease have been reported to a limited extent [71–75].
Vertebroplasty and kyphoplasty do not necessarily need
to be used as stand-alone treatments, although that has
usually been the case. Several exceptions have been pre-
sented however. For example, short-segment pedicle screw
ﬁxation has been augmented with PMMA in the setting of
thoracolumbar fractures to help maintain kyphotic correc-
tion and minimize hardware failure by providing additional
anterior column support [76, 77]. PMMA-augmented
constructs may also decrease hardware failure by increas-
ing pedicle screw pull-out strength [78]. Kyphoplasty has
also been combined with radiosurgery to treat pathological
compression fractures and avoid surgeries associated with
greater morbidity [79].
Conclusions
Vertebroplasty and kyphoplasty are relatively new tech-
niques for the treatment of pain caused by vertebral body
compression fractures. Kyphoplasty differs from verteb-
roplasty in that a balloon is ﬁrst inﬂated in the vertebral
body to create a cavity into which cement is then injected
under lower pressure. Theoretically, inﬂating the balloon
can increase vertebral height and reduce kyphotic defor-
mity, while injecting the cement under lower pressure can
minimize cement extravasation. There are no randomized
trials to compare the two procedures, and therefore the
available data only allow for indirect comparisons. On the
basis of systematic reviews of the literature, it appears that
patients undergoing either procedure achieve a comparable
reduction in pain. Biomechanical studies suggest that
kyphoplasty may initially be more effective in improving
vertebral height, but this effect is subsequently lost with
repetitive loading. These ﬁndings are consistent with
clinical studies, which have found little difference between
the procedures for improvement of vertebral height or
kyphotic deformity. Overall, complication rates for both
procedures are low; however, vertebroplasty appears to
have a higher rate of cement extravasation with associated
pulmonary emboli and compression of neural elements. As
the indications of vertebroplasty and kyphoplasty continue
to expand, well-designed randomized trials comparing the
two procedures directly are required to determine their
relative strengths and weaknesses in different clinical
scenarios.
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